Invest in life science

Capital Cell is the first European equity investment platform to specialise in life science, one of the fastest growing sectors in terms of investment raised*.  (Source: Beauhurst, The Deal: Equity Investment in the UK, Year 2016. p.7)

VALIDATED PROJECTS

At Capital Cell, we only publish projects which have been validated by:

  • Our in-house scientific, financial, legal and marketing departments
  • The BioExpert Network; a community of more than 500 scientists and investment professionals

SCIENTIFIC PROJECTS

The life science industry is a fast growing investment sector, providing investors with the opportunity to not only potentially benefit financially (in the event that a company achieves its forecasts and exit plans), but also benefit socially, knowing they’re influencing the future of the world around them.

UNDERSTAND RISKS

Although we cannot guarantee the future success of the companies we list on our platform, we perform financial and scientific analysis of each company that approaches us about fundraising. This way, we ensure only projects which are suitably prepared for investment are presented to investors.

INVEST IN THE FUTURE. INVEST IN LIFE SCIENCE

Innovation in life science changes lives. The Capital Cell investment platform provides investors with the opportunity to help advance fantastic life science companies from across Europe, in return for equity.